PlainRecalls
FDA Drug Low Class III Terminated

Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834; NDC 51862-295-10.

Reported: April 11, 2018 Initiated: March 21, 2018 #D-0616-2018

Product Description

Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834; NDC 51862-295-10.

Reason for Recall

Superpotent Drug: High out of specification results for tazarotene assay at the 9-month stability time point.

Details

Recalling Firm
Mayne Pharma Inc
Units Affected
3312 cans
Distribution
Nationwide in the USA
Location
Greenville, NC

Frequently Asked Questions

What product was recalled?
Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834; NDC 51862-295-10.. Recalled by Mayne Pharma Inc. Units affected: 3312 cans.
Why was this product recalled?
Superpotent Drug: High out of specification results for tazarotene assay at the 9-month stability time point.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 11, 2018. Severity: Low. Recall number: D-0616-2018.